
Heart drug trial failures at Novartis and Novo Nordisk leave experts searching for answers
An experimental Novartis (NVS) drug designed to treat a genetic cause of heart disease has failed to reduce deaths and non-fatal heart attacks, dashing hopes for the first of several similar medicines in clinical trials. Despite cutting…
